Vicky Demas is a chemical engineer focusing in diagnostics, point of care assays and nanotechnology, imaging, physiological and physiometric sensing. Vicky received her Bachelor's from the University of Illinois at Urbana-Champaign, while leading a three phase NASA/AFS sponsored project, including designing and running experiments on-board NASA’s KC-135 parabolic flights, using a metal analog to investigate fluid flow in solid-liquid interfaces during casting. She received her PhD from the University of California- Berkeley focusing on research to enable high-resolution NMR and MRI in inhomogeneous fields present in portable systems. She set up multiple international collaborations, and continued research as a fellow in portable magnetic resonance spectroscopy and imaging with lithography produced micro coils in the Lawrence Berkeley and Lawrence Livermore National Labs. After her postdoctoral fellowship, Vicky joined an early stage nanoparticle startup company (T2 Biosystems), where she was instrumental to the development of the first diagnostic instruments (T2Dx and T2MR) and cartridge. The company received FDA approval for its sepsis diagnostic system at the end of 2014. Vicky currently leads the biomedical systems engineering team in the Verily Research Group, focusing on the development of life sciences tools, imaging modalities, including endoscopic and physiometric applications.
